跳至主要内容
临床试验/NCT07480876
NCT07480876尚未招募不适用

Effect of Glyceryl Trinitrate Gel Phonophoresis in Treatment of Plantar Fasciitis: A Randomized Controlled Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2026年4月30日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
试验地点
1
主要终点
Ultrasonography

研究概览

简要总结

Does phonophoresis with glyceryl trinitrate gel have an effect in treatment of planter fasciitis patients?

详细描述

Plantar fasciitis (PF), considered the most common cause of sub-calcaneal pain, was first described in 1812, related to painful sensation in the calcaneus, resulting from degeneration of the plantar fascia. Some reported cases are the result of biomechanical failure that provides tension along the plantar fascia. It is a common dysfunction in runners, due to the high loads they exert on the plantar fascia, but other risk factors are also worth mentioning, such as increased planter flexion, high body mass and high body mass index phonophoresis emerges as a valuable and versatile modality within physiotherapy, demonstrating clinical efficacy across a spectrum of musculoskeletal and inflammatory conditions. The combination of topically applied gel or cream-based medications with ultrasound therapy, operating within specific frequency and intensity ranges, enhances percutaneous absorption of pharmacological agents.

Glyceryl trinitrate can directly relax vascular smooth muscles, especially the smooth muscle of small blood vessels, thus dilating blood vessels and improving the microcirculation. In addition, nitroglycerin interacts with intracellular sulfhydryl to release nitric oxide (NO). NO, as endothelial relaxing factor, activates guanylate cyclase to transform into cyclic guanosine monophosphate (cGMP), which increases cGMP in smooth muscles and other tissues, thereby causing dephosphorylation of myosin light chain, regulating the contractile state of smooth muscles, relaxing smooth muscles, and dilating blood vessels gap in literature about the effect of glyceryl trinitrate gel in treatment of plantar fasciitis. So the aim of this study is to investigate the effect of glyceryl trinitrate gel in treatment of plantar fasciitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18-44 years .
  • Patients BMI 18.5 to 24.9 kg / m
  • The diagnosis of PF appear clinically according to the history and physical - examination findings of point tenderness at or near the medial calcaneal insertion of the plantar fascia .
  • Diagnosis of plantar fasciitis, with plantar fascia of more than 4 mm thickness as evaluated by ultrasonography.
  • Painful symptoms lasting three months or more .

排除标准

  • Diabetes mellitus, peripheral neuropathy, vasculitis and vasculopathy.
  • Any pathology in ankle/foot (instability, arthritis, malignancy, acute infection, and skin disorders) .
  • Pregnancy or lactation, coronary artery disease, hypertension, renal diseases and anemia .
  • Atrophy/ scar or skin ulcers at the site of intervention.
  • Patients with allergy to nitrates.
  • Heart pacemaker use .
  • Anticoagulant use and absence of coagulation disease.

研究组 & 干预措施

ultrasound only and Therapeutic exercises

Active Comparator

干预措施: ultrasound only and Therapeutic exercises (Other)

Phonophoresis group

Experimental

Ultrasound will be used in addition to topical glyceryl trinitrate gel and therapeutic exercises.

干预措施: Phonophoresis group (Other)

结局指标

主要结局

Ultrasonography

时间窗: From enrollment to the end of treatment at 5 weeks

Patients with plantar fasciitis also typically have a thickened fascia. This change could be related to the reparative process of microtears, fiber degeneration, or edema. The average thickness of the plantar fascia in healthy individuals is between 2.2 and 3.6 mm. In patients with plantar fasciitis, it ranges from 4.6 to 6.1 mm. In general, individuals with a plantar fascia thicker than 4 mm are considered to have plantar fasciitis.

次要结局

  • visual analogue scale(From enrollment to the end of treatment at 5 weeks)
  • 6-Minu Walk Test(From enrollment to the end of treatment at 5 weeks)
  • Smartphone apps(From enrollment to the end of treatment at 5 weeks)
  • Arabic version of modified foot function index (FFI)(From enrollment to the end of treatment at 5 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fouad Sherin Fouad Ahmed

Assistant lecturer

Port Said University

研究点 (1)

Loading locations...

相似试验